BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: D'souza S, Lau KCK, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26(38): 5759-5783 [PMID: 33132633 DOI: 10.3748/wjg.v26.i38.5759]
URL: https://www.wjgnet.com/1948-5182/full/v26/i38/5759.htm
Number Citing Articles
1
Zhenyi Lv, Wenqi Gao, Zhiwei Du, Yi Zheng, Tianming Liu, Chenjun Hao, Dongbo Xue. Alternative splicing of IRF3 plays an important role in the development of hepatocarcinomaEpigenetics 2023; 18(1) doi: 10.1080/15592294.2023.2276371
2
Zijie Wu, Zehua Dong, Jiangti Luo, Weiwei Hu, Yue Tong, Xiangdong Gao, Wenbing Yao, Hong Tian, Xiaosheng Wang. A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysisGenomics 2024; 116(3): 110831 doi: 10.1016/j.ygeno.2024.110831
3
Patricia Martinez-Morales. Pathogens Associated with the Development of Cancer in Humans2024; : 513 doi: 10.1007/978-3-031-62558-9_22
4
Alessio Aghemo, Davide Polverini, Massimo Colombo. Hepatocellular Carcinoma in the Era of Direct Antiviral Agents Against Hepatitis C VirusCurrent Hepatology Reports 2024; 23(3): 364 doi: 10.1007/s11901-024-00664-5
5
Jacek Baj, Magdalena Kołodziej, Joanna Kobak, Jacek Januszewski, Kinga Syty, Piero Portincasa, Alicja Forma. Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma—From Inflammation to Hepatocellular Carcinoma ProgressionInternational Journal of Molecular Sciences 2024; 25(19): 10233 doi: 10.3390/ijms251910233
6
Junrui Tian, Jian Ma. The Value of Microbes in Cancer Neoantigen ImmunotherapyPharmaceutics 2023; 15(8): 2138 doi: 10.3390/pharmaceutics15082138
7
Thi Tra Bui, Eunjung Park, Hee‐Yeon Kang, Jin‐Kyoung Oh. Combined effects of smoking and alcohol consumption on the risk of liver cancer according to metabolic syndrome: A nested case–control study in South KoreaInternational Journal of Cancer 2024; 155(4): 654 doi: 10.1002/ijc.34935
8
Shahab Mahmoudvand, Somayeh Shokri, Mohsen Nakhaie, Farid Azizi Jalilian, Ameneh Mehri-Ghahfarrokhi, Reza Yarani, Ali Shojaeian. Small extracellular vesicles as key players in cancer development caused by human oncogenic virusesInfectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00471-x
9
Gemechu Ameya, Dagim Jirata Birri. The molecular mechanisms of virus-induced human cancersMicrobial Pathogenesis 2023; 183: 106292 doi: 10.1016/j.micpath.2023.106292
10
Chen Shen, Xin Jiang, Mei Li, Yao Luo. Hepatitis Virus and Hepatocellular Carcinoma: Recent AdvancesCancers 2023; 15(2): 533 doi: 10.3390/cancers15020533
11
Chern-Horng Lee, Chien-Heng Shen, Cho-Li Yen, Tzung-Hai Yen, Sen-Yung Hsieh. Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative TherapyJournal of Personalized Medicine 2023; 13(3): 397 doi: 10.3390/jpm13030397
12
Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei. AIF1+CSF1R+ MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesisHepatology 2023; 78(2): 434 doi: 10.1002/hep.32738
13
Yanxu Li, Hao Zou, Zekun Zheng, Zhuoheng Liu, Huiyuan Hu, Wei Wu, Tao Wang. Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual CancerInternational Journal of Nanomedicine 2023; : 2721 doi: 10.2147/IJN.S399146
14
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma DevelopmentCancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
15
Junjie Yin, Mian Wang, Jian Chen, Huigang Li, Jianyong Zhuo, Bei Lu, Yang Cai. CircZCCHC2 (hsa_circ_0000854) promotes hepatocellular carcinoma progression through modulating miR-936/BTBD7 axis and activating Rho/ROCK2 pathwayNon-coding RNA Research 2024; 9(2): 437 doi: 10.1016/j.ncrna.2023.12.004
16
Bao-Kang Wu, Qian-Hui Chen, Dan Pan, Bing Chang, Li-Xuan Sang. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancerInternational Immunopharmacology 2021; 96: 107790 doi: 10.1016/j.intimp.2021.107790
17
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancementsWorld Journal of Gastroenterology 2021; 27(24): 3466-3482 doi: 10.3748/wjg.v27.i24.3466
18
Mustafa Ahmed Yousif, Ibrahim Siddig Mohammed, Siddig Osman Mohammed, Maab Elyas Gebreel, Rayan Mohammed Alhaj, Duha Atef Alsier, Hadia Babiker Abdelbasit, Habab Merghani Yassin, Lienda Bashier Eltayeb. Nosocomial Transmission of Hepatitis B Surface Antigen and Anti-Hepatitis C Virus among Hemodialysis PatientsArchives Of Pharmacy Practice 2022; 13(3): 5 doi: 10.51847/LCcAdvtrzs
19
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas, Urania Georgopoulou. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and CargoInternational Journal of Molecular Sciences 2022; 23(18): 10862 doi: 10.3390/ijms231810862
20
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and AutophagyBiomedicines 2023; 11(4): 1166 doi: 10.3390/biomedicines11041166
21
Mohsen Amirnorouzi, Ahmadmoeen Karimi, Naser Ebrahimi Daryani, Amiratabak Rajaei, Mehrdad Hashemi, Masoud Alebouyeh. Negative feedback loop in the activation of non-homologous end joining DNA repair pathway in Helicobacter pylori infected patients with gastritisScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-74138-5
22
Yanning Li. Virus vaccines in cancer immunotherapy: Principles, and Clinical manifestationsHighlights in Science, Engineering and Technology 2022; 14: 338 doi: 10.54097/hset.v14i.1843
23
Youpeng Wang, Yeni Yang, Ziyin Zhao, Hongfa Sun, Dingan Luo, Lakshmi Huttad, Bingyuan Zhang, Bing Han. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cellsBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09465-9
24
Qu Xie, Zeyin Zhao, Yanzhen Yang, Dan Long, Cong Luo. Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resectionJournal of Cancer Research and Clinical Oncology 2023; 149(16): 14983 doi: 10.1007/s00432-023-05291-z
25
Maowen Yu, Chaozhu Zhang, Hongbo Tang, Chaohui Xiao, Hangjun Che. Correlation between Serum Oxidative Stress Level and Serum Uric Acid and Prognosis in Patients with Hepatitis B-Related Liver Cancer before OperationJournal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/1964866
26
Theerut Luangmonkong, Pittaya Puphancharoensuk, Varisara Tongsongsang, Peter Olinga, Warisara Parichatikanond. Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated MiceBiomedicines 2023; 11(1): 231 doi: 10.3390/biomedicines11010231
27
Hang Wang, Bobin Hu, Hengkai Liang, Rongming Wang, Lu Wei, Tumei Su, Qingmei Li, Qianbing Yin, Yanfei Feng, Minghua Su, Jianning Jiang. Impact of HBV Integration on Hepatocellular Carcinoma After Long-Term Antiviral TherapyInternational Journal of General Medicine 2024; : 2643 doi: 10.2147/IJGM.S462844
28
Yingxu Fang, Zehui Lei, Lingqiang Zhang, Cui Hua Liu, Qiyao Chai. Regulatory functions and mechanisms of human microbiota in infectious diseaseshLife 2024; 2(10): 496 doi: 10.1016/j.hlife.2024.03.004
29
Po-Shuan Huang, Ling-Yu Wang, Yi-Wen Wang, Ming-Ming Tsai, Tzu-Kang Lin, Chia-Jung Liao, Chau-Ting Yeh, Kwang-Huei Lin. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver CancerCells 2023; 12(6): 869 doi: 10.3390/cells12060869
30
Chia-Chen Chen, Guiwen Guan, Xuewei Qi, Abudurexiti Abulaiti, Ting Zhang, Jia Liu, Fengmin Lu, Xiangmei Chen. Pacbio Sequencing of PLC/PRF/5 Cell Line and Clearance of HBV Integration Through CRISPR/Cas-9 SystemFrontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.676957
31
Yung-Tsung Li, Hui-Lin Wu, Chun-Jen Liu. Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1International Journal of Molecular Sciences 2021; 22(17): 9380 doi: 10.3390/ijms22179380
32
Theerut Luangmonkong, Warisara Parichatikanond, Peter Olinga. Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challengesBiochemical Pharmacology 2023; 215: 115740 doi: 10.1016/j.bcp.2023.115740
33
Dallyla Jennifer Morais de Sousa, Kynnara Gabriella Feitosa de Oliveira, Irislene Costa Pereira, Glauto Tuquarre Melo do Nascimento, Clenio Oliveira Barrense, Jorddam Almondes Martins, Beatriz de Mello Pereira Rêgo, Tiago Eugênio Oliveira da Silva, Felipe Cavalcanti Carneiro da Silva, Francisco Leonardo Torres-Leal. Dietary restriction and hepatic cancer: Systematic review and meta-analysis of animal studiesCritical Reviews in Oncology/Hematology 2024; 196: 104264 doi: 10.1016/j.critrevonc.2024.104264
34
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Long noncoding RNAs in hepatitis B virus replication and oncogenesisWorld Journal of Gastroenterology 2022; 28(25): 2823-2842 doi: 10.3748/wjg.v28.i25.2823
35
Sha Li, Wen Liu, Tong‐Tong Wang, Tong‐Qiang Chen, Jin‐Cai Guo. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experimentsChemical Biology & Drug Design 2024; 103(1) doi: 10.1111/cbdd.14428
36
Yiwen Liu, Fuyou Zhou, Haijun Yang, Zheyuan Zhang, Jiahao Zhang, Keyao He, Mengfan Qian, Ruonan Li, Wei Sun, Ningtao Dai, Junkuo Li, Yibo Guo, Jinyu Kong, Shegan Gao. Porphyromonas gingivalis promotes malignancy and chemo-resistance via GSK3β-mediated mitochondrial oxidative phosphorylation in human esophageal squamous cell carcinomaTranslational Oncology 2023; 32: 101656 doi: 10.1016/j.tranon.2023.101656
37
An Tu, Xiaoning Zhu, Paniz Zarghami Dastjerdi, Yue Yin, Mengyun Peng, Ding Zheng, Zhaoxuan Peng, Encheng Wang, Xiaodong Wang, Wang Jing. Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysisHeliyon 2024; 10(3): e24437 doi: 10.1016/j.heliyon.2024.e24437
38
Linlin Jiang, Qin Meng, Lixiu Liu, Weihang Li. A Comprehensive Review on Molecular Mechanisms, Treatments, and Brief Role of Natural Products in Hepatocellular CancerNatural Product Communications 2024; 19(9) doi: 10.1177/1934578X241284873
39
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting AntiviralsCancers 2022; 14(11): 2700 doi: 10.3390/cancers14112700
40
Abubakar Yaro, Svetoslav Martinov, Catherine Johnson. Efficacy of combined antiretroviral therapy (cART) in Hepatitis B and C associated hepatocellular carcinoma (HCC): a narrative reviewJournal of Human Virology & Retrovirology 2023; 10(3): 73 doi: 10.15406/jhvrv.2023.10.00271
41
Cynthia H. Chiu. CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discoveryCurrent Research in Biotechnology 2023; 5: 100127 doi: 10.1016/j.crbiot.2023.100127
42
Yi Bai, Juan Xu, Deqiang Li, Xiaoyu Zhang, Dapeng Chen, Fucun Xie, Longmei Huang, Xiaotian Yu, Haitao Zhao, Yamin Zhang. HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinomaClinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01508-7
43
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, Esam Ibraheem Azhar. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overviewFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913231
44
Xiaolong Tang, Yandong Miao, Jiangtao Wang, Teng Cai, Lixia Yang, Denghai Mi, Po-Hsiang Tsui. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular CarcinomaComputational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/1205029
45
Mengfei Sheng, Yuanyuan Zhang, Yaoyun Wang, Weiyi Liu, Xingyu Wang, Tiaoying Ke, Pingyang Liu, Sihan Wang, Wei Shao. Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive reviewJournal of Cancer Research and Clinical Oncology 2023; 149(19): 17691 doi: 10.1007/s00432-023-05474-8
46
Basil Alawyia, Constantina Constantinou. Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future ProspectsCurrent Treatment Options in Oncology 2023; 24(7): 711 doi: 10.1007/s11864-023-01098-9
47
Juris Jansons, Dace Skrastina, Alisa Kurlanda, Stefan Petkov, Darya Avdoshina, Yulia Kuzmenko, Olga Krotova, Olga Trofimova, Ilya Gordeychuk, Irina Sominskaya, Maria Isaguliants. Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV-Related Liver CancerMicroorganisms 2021; 9(5): 1073 doi: 10.3390/microorganisms9051073
48
Akshatha N. Srinivas, Diwakar Suresh, Savneet Kaur, Divya P. Kumar. The promise of small particles: extracellular vesicles as biomarkers in liver pathologyThe Journal of Physiology 2023; 601(22): 4953 doi: 10.1113/JP283074
49
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Chidi V Nnabuchi, Ponsiano Ocama, Edith Okeke, John Rwegasha, Abate B Shewaye, Fatuma F Some, Christian Tzeuton, Mark W Sonderup. Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan AfricaThe Lancet Gastroenterology & Hepatology 2022; 7(11): 1036 doi: 10.1016/S2468-1253(22)00041-3
50
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, Xuan Liu, Zhe-Sheng Chen. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategiesCancer Letters 2024; 597: 217061 doi: 10.1016/j.canlet.2024.217061
51
Wen Jia, Yang Bi. Retinoic acids and nuclear receptor signaling in liver development: Pathogenic roles in liver diseasesPediatric Discovery 2024; 2(1) doi: 10.1002/pdi3.29
52
Kaixuan Xu, Xinxin Wang, Shuwei Hu, Jiaxuan Tang, Shihui Liu, Hui Chen, Xiaobin Zhang, Penggao Dai. LINC00540 promotes sorafenib resistance and functions as a ceRNA for miR-4677-3p to regulate AKR1C2 in hepatocellular carcinomaHeliyon 2024; 10(5): e27322 doi: 10.1016/j.heliyon.2024.e27322
53
Jingjing Zhang, Qingrong Zhang, Wenyan Hu, Yuxuan Liang, Deke Jiang, Haitao Chen. A transcriptome-wide association study identified susceptibility genes for hepatocellular carcinoma in East AsiaGastroenterology Report 2023; 12 doi: 10.1093/gastro/goae057
54
Iman M. El-Zehery, Mohamed El-Mesery, Mohamed El-Sherbiny, Amal M. El Gayar, Nada H. Eisa. Carbenoxolone upregulates TRAIL\TRAILR2 expression and enhances the anti-neoplastic effect of doxorubicin in experimentally induced hepatocellular carcinoma in ratsBiochemical and Biophysical Research Communications 2024; : 150876 doi: 10.1016/j.bbrc.2024.150876
55
Zachary J. Brown, Samantha M. Ruff, Timothy M. Pawlik. The effect of liver disease on hepatic microenvironment and implications for immune therapyFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1225821
56
Rui Huang, Kun Yang, Zejuan Zhang, Lei Song, Kaizhong Dong, Xiaofeng Xie, Xiangjun Hai. Mongolian HCC vs. Caucasian HCC: The Metabolic Reprogramming Process in Mongolian HCC is an Interesting DifferenceBiochemical Genetics 2024; 62(3): 2279 doi: 10.1007/s10528-023-10527-1
57
Ana Banko, Danijela Miljanovic, Andja Cirkovic. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new fieldInternational Journal of Infectious Diseases 2023; 130: 108 doi: 10.1016/j.ijid.2023.01.036
58
Ahmed Gaballah, Birke Bartosch. An Update on the Metabolic Landscape of Oncogenic VirusesCancers 2022; 14(23): 5742 doi: 10.3390/cancers14235742
59
Toofan Datfar, Michael Doulberis, Apostolis Papaefthymiou, Ian N. Hines, Giulia Manzini. Viral Hepatitis and Hepatocellular Carcinoma: State of the ArtPathogens 2021; 10(11): 1366 doi: 10.3390/pathogens10111366
60
Jeffrey V. Lazarus, Camila A. Picchio, Massimo Colombo. Hepatocellular Carcinoma Prevention in the Era of Hepatitis C EliminationInternational Journal of Molecular Sciences 2023; 24(18): 14404 doi: 10.3390/ijms241814404
61
Ema Elvira Herrera-López, Dafne Guerrero-Escalera, Isaac Aguirre-Maldonado, Arely López-Hernández, Hilda Montero, María Angélica Gutiérrez‐Nava, Luis del Pozo-Yauner, Jaime Arellanes-Robledo, Javier Camacho, Julio Isael Pérez-Carreón. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesisScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34117-8
62
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practicesExpert Review of Gastroenterology & Hepatology 2021; 15(5): 487 doi: 10.1080/17474124.2021.1900732
63
Yen-Ju Chen, Chih-Jung Shen, Shao-Hua Yu, Cheng-Li Lin, Hong-Mo Shih. Increased risk of hepatocellular carcinoma in patients with traumatic liver injuryMedicine 2022; 101(6): e28837 doi: 10.1097/MD.0000000000028837
64
Association between ascites Gustave Roussy immune score and the intratumoural microbiome in malignant ascites secondary to hepatocellular carcinomaInternational Immunopharmacology 2024; 133: 112097 doi: 10.1016/j.intimp.2024.112097
65
Ying Liu, Chunhai Hao, Lei Li, Haiguang Zhang, Weina Zha, Longbin Ma, Li Chen, Jianhe Gan. The Role of Oxidative Stress in the Development and Therapeutic Intervention of Hepatocellular CarcinomaCurrent Cancer Drug Targets 2023; 23(10): 792 doi: 10.2174/1568009623666230418121130
66
Ashraf Elbahrawy, Hassan Atalla, Abdulla A. Mahmoud, Ahmed Eliwa, Alaa Alsawak, Mohamed Alboraie, Ali Madian, Ahmed Alashker, Sadek Mostafa, Ahmed Alwassief, Hussein H. Aly. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agentsFrontiers in Virology 2023; 3 doi: 10.3389/fviro.2023.1227317
67
Wanting Shi, Kang Li, Yonghong Zhang. Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCCFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1185142
68
Huizhong Shi, Wenwen Zhang, Bingyang Hu, Yafei Wang, Ze Zhang, Ying Sun, Guankun Mao, Chonghui Li, Shichun Lu. Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrenceHepatology International 2023; 17(2): 393 doi: 10.1007/s12072-022-10457-x
69
Vuyolwethu Khwaza, Buhle Buyana, Xhamla Nqoro, Sijongesonke Peter, Zintle Mbese, Zizo Feketshane, Sibusiso Alven, Blessing A. Aderibigbe. Viral Infections and Antiviral Therapies2023; : 407 doi: 10.1016/B978-0-323-91814-5.00018-0
70
Marianela Giorgio, Kelly Alejandra Ramírez Ladino, Guido López, Maricel Sosa Rojas, Estela Outon, Cecilia María Delfino. Frequency of hepatitis D virus with different hepatitis B virus serological markers and coinfections in hospital patients from Argentina: synchronous testing of anti-HDV antibodies and HDV RNAEuropean Journal of Gastroenterology & Hepatology 2024;  doi: 10.1097/MEG.0000000000002857
71
Xia Yin, Fanggong Kan. Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysisCancer Epidemiology 2023; 87: 102457 doi: 10.1016/j.canep.2023.102457
72
Elisabeth Digifico, Silvia Balinzo, Cristina Belgiovine. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor OnsetInternational Journal of Molecular Sciences 2021; 22(3): 1224 doi: 10.3390/ijms22031224
73
Ryosuke Suzuki, Tetsuro Suzuki. Reverse Genetics of RNA VirusesMethods in Molecular Biology 2024; 2733: 175 doi: 10.1007/978-1-0716-3533-9_11
74
Song Gao, Xingyue Jiang, Liang Wang, Shanshan Jiang, Hanyuan Luo, Yan Chen, Cheng Peng. The pathogenesis of liver cancer and the therapeutic potential of bioactive substancesFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1029601
75
Yu Min, Xiaoyuan Wei, Xi Xia, Zhigong Wei, Ruidan Li, Jing Jin, Zheran Liu, Xiaolin Hu, Xingchen Peng. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer riskFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1141956
76
Gerardo B. Figueroa, Simmone D'souza, Higor S. Pereira, Gunjan Vasudeva, Sara B. Figueroa, Zachary E. Robinson, Maulik D. Badmalia, Vanessa Meier‐Stephenson, Jennifer A. Corcoran, Guido van Marle, Yi Ni, Stephan Urban, Carla S. Coffin, Trushar R. Patel. Development of a single‐domain antibody to target a G‐quadruplex located on the hepatitis B virus covalently closed circular DNA genomeJournal of Medical Virology 2024; 96(6) doi: 10.1002/jmv.29692
77
Xiaoming Shi, Ni Li. Progress in China Epidemiology2022; : 215 doi: 10.1007/978-981-19-2199-5_10
78
Xiaoyu Li, Masahiko Ito, Haruyo Aoyagi, Asako Murayama, Hideki Aizaki, Masayoshi Fukasawa, Takanobu Kato, Takaji Wakita, Tetsuro Suzuki. Development and Use of a Kinetical and Real-Time Monitoring System to Analyze the Replication of Hepatitis C VirusInternational Journal of Molecular Sciences 2022; 23(15): 8711 doi: 10.3390/ijms23158711
79
Angelo Bruni, Chiara Castellana, Elton Dajti, Giovanni Barbara, Giovanni Marasco, Marcello Maida, Gaetano Serviddio, Antonio Facciorusso. Epidemiological, diagnostic, therapeutic and prognostic impact of hepatitis B and D virus infection on hepatocellular carcinoma: A review of the literatureVirology 2024; 600: 110273 doi: 10.1016/j.virol.2024.110273
80
Amanda Jean Craig, Xin Wei Wang. Hepatitis B Virus and Liver Disease2021; : 123 doi: 10.1007/978-981-16-3615-8_6
81
Andrea L. Rosenkranz, Kyle C. Yeakle, Michael J. Bouchard. Molecular Medical Microbiology2024; : 2261 doi: 10.1016/B978-0-12-818619-0.00157-X
82
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxì. Hepatitis B Virus-Associated Hepatocellular CarcinomaViruses 2022; 14(5): 986 doi: 10.3390/v14050986
83
Yu Jiang, Qiuju Han, Huajun Zhao, Jian Zhang. The Mechanisms of HBV-Induced Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2021; : 435 doi: 10.2147/JHC.S307962
84
Xue Pang, Wei Wan, Xingxing Wu, Yu Shen, Ferenc Olasz. The Novel Action of miR-193b-3p/CDK1 Signaling in HCC Proliferation and Migration: A Study Based on Bioinformatic Analysis and Experimental InvestigationInternational Journal of Genomics 2022; 2022: 1 doi: 10.1155/2022/8755263
85
Aref Yarahmadi, Mitra Zare, Masoomeh Aghayari, Hamed Afkhami, Gholam Ali Jafari. Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for futureCell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01622-w
86
Jingyuan Zhang, Zhihong Huang, Xinkui Liu, Chao Wu, Wei Zhou, Peizhi Ye, Antony Stalin, Shan Lu, Yingying Tan, Zhishan Wu, Xiaotian Fan, Xiaomeng Zhang, Miaomiao Wang, Bingbing Li, Guoliang Cheng, Yanfang Mou, Jiarui Wu, Shibiao Wan. Exploring the Multicomponent Synergy Mechanism of Yinzhihuang Granule in Inhibiting Inflammation-Cancer Transformation of Hepar Based on Integrated Bioinformatics and Network PharmacologyBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/6213865
87
Mohiniso B. Hidirova, Abrorjon M. Turgunov. A Method for Modeling the Regulation of the Introduction of Genetic Information of the Hepatitis B Virus into the Hepatocyte Genome2024 IEEE 25th International Conference of Young Professionals in Electron Devices and Materials (EDM) 2024; : 2480 doi: 10.1109/EDM61683.2024.10615136
88
James Lok, Kosh Agarwal. Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An UpdateViruses 2021; 13(7): 1333 doi: 10.3390/v13071333
89
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinomaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728
90
Thomas M. Ruli, Ethan D. Pollack, Atul Lodh, Charles D. Evers, Christopher A. Price, Mohamed Shoreibah. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A ReviewCancers 2024; 16(11): 2042 doi: 10.3390/cancers16112042
91
Saleh A. Alqahtani, Massimo Colombo. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular CarcinomaCells 2021; 10(11): 3091 doi: 10.3390/cells10113091
92
Gulzhanat Nurlanova, Aigerim Iskakova, Akezhan Astrakhanov, Aigul Amanzhanova, Galina Zhumagaliyeva. Polymorphism of the TLR3 gene in Predisposition to Chronic Viral Hepatitis B and C in the population of Turkic-speaking peoplesResearch Journal of Pharmacy and Technology 2024; : 2699 doi: 10.52711/0974-360X.2024.00423
93
Bingqian Qu, Firat Nebioglu, Mila M. Leuthold, Yi Ni, Pascal Mutz, Jürgen Beneke, Holger Erfle, Florian W.R. Vondran, Ralf Bartenschlager, Stephan Urban. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigenJHEP Reports 2022; 4(10): 100551 doi: 10.1016/j.jhepr.2022.100551
94
Edward R. Cachay, Colleen Hadigan, Wm. Christopher Mathews. Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevailAIDS 2021; 35(13): 2211 doi: 10.1097/QAD.0000000000003022
95
Kai Zhang, Anna E. Barry, Ryan Lamm, Keyur Patel, Michelle Schafer, Hien Dang. The role of RNA binding proteins in hepatocellular carcinomaAdvanced Drug Delivery Reviews 2022; 182: 114114 doi: 10.1016/j.addr.2022.114114
96
Yibin Che, Ge Wang, Qiang Xia. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinomaFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.937310
97
Marwa Ahmed Sakr, Khaled Abdel Hamid Mohamed, Ahmed Mohamed Hussein, Mohamed Hassan Fouad, Ahmed Samir Allam, Eslam Safwat. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapyEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00090-y
98
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An updateWorld Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
99
Juliet A. Shenge, Carla Osiowy. Rapid Diagnostics for Hepatitis B and C Viruses in Low- and Middle-Income CountriesFrontiers in Virology 2021; 1 doi: 10.3389/fviro.2021.742722
100
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco. The Role of Hepatitis Viruses as Drivers of HepatocancerogenesisCancers 2024; 16(8): 1505 doi: 10.3390/cancers16081505
101
Pinelopi Samara, Michail Athanasopoulos, Stylianos Mastronikolis, Efthymios Kyrodimos, Ioannis Athanasopoulos, Nicholas S. Mastronikolis. The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection MethodsMicroorganisms 2024; 12(7): 1482 doi: 10.3390/microorganisms12071482
102
Jian Xu, Yao Zhou, Ke Dong, Jun Gong, Wei Xiong, Xu Wang, Chun Gu, Xiang-yu Lu, De-pei Huang, Xu-dong Shen, Xue-ke She, Xiao-chen Zhao, Xiao-jiong Yu, Hao Zhang. Gene variation profile and its potential correlation with clinical characteristics in HBV-associated HCC patients of Sichuan Han nationality in ChinaAsian Journal of Surgery 2023; 46(10): 4371 doi: 10.1016/j.asjsur.2023.02.056
103
Héloïse Leroy, Mingyu Han, Marie Woottum, Lucie Bracq, Jérôme Bouchet, Maorong Xie, Serge Benichou. Virus-Mediated Cell-Cell FusionInternational Journal of Molecular Sciences 2020; 21(24): 9644 doi: 10.3390/ijms21249644
104
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, Lorenzo Ventriglia, Marina Cipullo, Annachiara Coppola, Chiara Tammaro, Giuseppe Scafuro, Patrizia Iodice, Alessandro Federico. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic ImplicationsCancers 2023; 15(21): 5178 doi: 10.3390/cancers15215178
105
Haruyo Aoyagi, Hiroko Iijima, Eman S. Gaber, Takuma Zaitsu, Mami Matsuda, Kosho Wakae, Koichi Watashi, Ryosuke Suzuki, Takahiro Masaki, Jeffrey Kahn, Takeshi Saito, Mohamed El‐Kassas, Noritomo Shimada, Keizo Kato, Masaru Enomoto, Kazuhiko Hayashi, Akihito Tsubota, Ayako Mimata, Yuriko Sakamaki, Shizuko Ichinose, Masamichi Muramatsu, Kenjiro Wake, Takaji Wakita, Hideki Aizaki. Hepatocellular organellar abnormalities following elimination of hepatitis C virusLiver International 2023; 43(8): 1677 doi: 10.1111/liv.15624
106
Lihong Shen, Lijia Shao, Shengchun Feng. Preoperative serum glutathione reductase activity and alpha-fetoprotein level are associated with early postoperative recurrence of hepatocellular carcinomaJournal of Laboratory Medicine 2024;  doi: 10.1515/labmed-2024-0035
107
Jin Yang, Kai He, Mengyu Zhang, Lile Wu, Shu Qin, Ming Luo, Xianming Xia. Unveiling the therapeutic potential of epigallocatechin gallate in liver cancer: insights from network pharmacology and in vitro assays Natural Product Research 2024; : 1 doi: 10.1080/14786419.2024.2384083
108
Noha H. Habashy, Shaimaa A. Olleak, Marwa M. Abu-Serie, Nadia Z. Shaban. A new approach for the treatment of bleomycin-induced rat pulmonary injury by combined protein fraction of major royal jelly protein 2 and its isoform X1Biomedicine & Pharmacotherapy 2023; 167: 115578 doi: 10.1016/j.biopha.2023.115578
109
Jiamin Gao, Zhijian Li, Qinchen Lu, Jialing Zhong, Lixin Pan, Chao Feng, Shaomei Tang, Xi Wang, Yuting Tao, Jianyan Lin, Qiuyan Wang. Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinomaFrontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1194199
110
Lanqian Su, Huanyu Luo, Yalan Yan, Zhongqiu Yang, Jiaan Lu, Danqi Xu, Linjuan Du, Jie Liu, Guanhu Yang, Hao Chi. Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinomaFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1433540
111
Wenze Wu, Fang Lin, Zifan Chen, Kejia Wu, Changhuan Ma, Jing Zhuang, Donglin Sun, Qiang Zhu, Longqing Shi. Identification of hub genes associated with hepatitis B virus-related hepatocellular cancer using weighted gene co-expression network analysis and protein-protein interaction network analysisItalian Journal of Medicine 2023; 17(2) doi: 10.4081/itjm.2023.1626
112
Evgeniya A. Antropova, Tamara M. Khlebodarova, Pavel S. Demenkov, Anastasiia R. Volianskaia, Artur S. Venzel, Nikita V. Ivanisenko, Alexandr D. Gavrilenko, Timofey V. Ivanisenko, Anna V. Adamovskaya, Polina M. Revva, Nikolay A. Kolchanov, Inna N. Lavrik, Vladimir A. Ivanisenko. Reconstruction of the regulatory hypermethylation network controlling hepatocellular carcinoma development during hepatitis C viral infectionJournal of Integrative Bioinformatics 2024; 20(3) doi: 10.1515/jib-2023-0013
113
Zhiyi Li, Ying Zhang, Baipan Zhang, Rui Guo, Minhua He, Zi-Ling Liu, Lei Yang, Hong Wang. Bibliometric study of immunotherapy for hepatocellular carcinomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1210802
114
Daria Apostolo, Luciana L. Ferreira, Federica Vincenzi, Nicole Vercellino, Rosalba Minisini, Federico Latini, Barbara Ferrari, Michela E. Burlone, Mario Pirisi, Mattia Bellan. From MASH to HCC: the role of Gas6/TAM receptorsFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1332818
115
Yuan Tian, Wenwen Han, Long Fu, Kaiji Lv, Shugeng Wu. CDCA7 serves as a novel prognostic marker in human hepatocellular carcinomaBiotechnology and Genetic Engineering Reviews 2024; 40(4): 4696 doi: 10.1080/02648725.2023.2216072
116
Enhua Shen, Jingzhi Zhang, Yujuan Lu. DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23)Bioengineered 2022; 13(1): 1103 doi: 10.1080/21655979.2021.2017629
117
Shahrzad Shoraka, Seyed Mahdi Hosseinian, Ayda Hasibi, Amir Ghaemi, Seyed Reza Mohebbi. The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathwaysFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213145
118
Hao Zhang. Quantitative PCR-based high-sensitivity detection of HBV-DNA levels reflects liver function deterioration in patients with hepatitis B virus-related cirrhosisAmerican Journal of Translational Research 2024; 16(6): 2301 doi: 10.62347/BDLO2786
119
Vaia Valiakou, Petros Eliadis, Eirini Karamichali, Ourania Tsitsilonis, John Koskinas, Urania Georgopoulou, Pelagia Foka. Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and TreatmentInternational Journal of Molecular Sciences 2021; 22(15): 7961 doi: 10.3390/ijms22157961
120
Elizabeth S. Borden, Annika Jorgensen, Heini M. Natri, Karen Taraszka Hastings, Kenneth H. Buetow, Melissa A. Wilson. HCV- and HBV-mediated liver cancer converge on similar transcriptomic landscapes and immune profilesHuman Genetics and Genomics Advances 2025; 6(1): 100373 doi: 10.1016/j.xhgg.2024.100373
121
Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann, Daniel Todt, Eike Steinmann. Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular CarcinomaCancers 2021; 13(22): 5867 doi: 10.3390/cancers13225867
122
Linjun Liang, Xiaoyan Wang, Shuying Huang, Yanwei Chen, Peng Zhang, Liang Li, Yong Cui. Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1046771
123
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 33 doi: 10.1016/B978-0-323-98806-3.00023-4
124
Naoko Murata‐Kamiya, Masanori Hatakeyama. Helicobacter pylori‐induced DNA double‐stranded break in the development of gastric cancerCancer Science 2022; 113(6): 1909 doi: 10.1111/cas.15357
125
Samira Dziri, Christophe Rodriguez, Athenaïs Gerber, Ségolène Brichler, Chakib Alloui, Dominique Roulot, Paul Dény, Jean Michel Pawlotsky, Emmanuel Gordien, Frédéric Le Gal. Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV GenotypeViruses 2021; 13(8): 1572 doi: 10.3390/v13081572
126
Xubo Huang, Joseph T. Glessner, Jinxia Huang, Desheng Zhou, Michael E. March, Hongna Wang, Qianghua Xia, Hakon Hakonarson, Jin Li. Discovery of Novel Host Molecular Factors Underlying HBV/HCV InfectionFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.690882
127
Alessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, Monica Cucco, Giulio V Dalla Riva, Edoardo G Giannini, Fabio Piscaglia, Gianludovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Filomena Morisco, Antonio Gasbarrini, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Filippo Pelizzaro, Rafael Ramirez Morales, Umberto Cillo, Franco Trevisani, Luca Miele, Giulio Marchesini, Fabio Farinati. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA databaseGut 2023; 72(1): 141 doi: 10.1136/gutjnl-2021-324915
128
EV Khorkova, LV Lyalina, OM Mikailova, AYu Kovelenov, YuV Ostankova, DE Valutite, TA Stasishkis, VV Tsvetkov, KE Novak, OYu Rishnyak, IV Kritskaya, LV Buts, DS Tyagunov. Current Issues of Epidemiological Surveillance of Chronic Viral Hepatitis B, C, D and Hepatocellular Carcinoma at the Regional LevelЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2021; : 76 doi: 10.35627/2219-5238/2021-29-8-76-84
129
Ricardo Diaz-Aragon, Michael C. Coard, Sriram Amirneni, Lanuza Faccioli, Nils Haep, Michelle R. Malizio, Takashi Motomura, Zehra N. Kocas-Kilicarslan, Alina Ostrowska, Rodrigo M. Florentino, Carla Frau. Therapeutic Potential of HNF4α in End-stage Liver DiseaseOrganogenesis 2021; 17(3-4): 126 doi: 10.1080/15476278.2021.1994273
130
Shuling Wu, Liu Yang, Xiaoyue Bi, Yanjie Lin, Wen Deng, Tingting Jiang, Minghui Li, Yao Xie. Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virusGastroenterology & Endoscopy 2023; 1(1): 5 doi: 10.1016/j.gande.2022.10.001
131
Emine Karaca Sulukoğlu, Şükran Günaydın, Şeyda Nur Kalın, Ahmet Altay, Harun Budak. Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(8): 5745 doi: 10.1007/s00210-024-02980-5
132
Janos Minarovits. Human tumor viruses: induction of three-dimensional alterations in the host genome structureFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1280210
133
Lienda Bashier Eltayeb, Deema I Fallatah, Altaf Ali Mangi. Genomic divergence of Hepatitis C virus towards common prescribed interferon regimens on sustained virologic response (SVR) ‎Journal Of Advanced Pharmacy Education And Research 2022; 12(3): 59 doi: 10.51847/EJ82rOFBiq
134
Lizhi Cao, Xiaoying Wang, Xin Li, Linlin Ma, Yanfei Li. Identification of Co-diagnostic Genes for Heart Failure and Hepatocellular Carcinoma Through WGCNA and Machine Learning AlgorithmsMolecular Biotechnology 2024; 66(5): 1229 doi: 10.1007/s12033-023-01025-1
135
E. A. Antropova, T. M. Khlebodarova, P. S. Demenkov, A. S. Venzel, N. V. Ivanisenko, A.  D.  Gavrilenko, T.  V. Ivanisenko, A. V. Adamovskaya, P. M. Revva, I. N. Lavrik, V. A. Ivanisenko. Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteinsVavilov Journal of Genetics and Breeding 2023; 26(8): 733 doi: 10.18699/VJGB-22-89
136
Junying Wang, Guangyu Zhu. Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β‑catenin pathway in liver cancerOncology Letters 2023; 26(4) doi: 10.3892/ol.2023.14034
137
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang. The Roles of Myeloid-Derived Suppressor Cells in Liver DiseaseBiomedicines 2024; 12(2): 299 doi: 10.3390/biomedicines12020299
138
Tianfeng Sun, Jing Zhang. ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progressionThe Journal of Biochemistry 2021; 170(5): 663 doi: 10.1093/jb/mvab088
139
Alkistis Papatheodoridi, George Papatheodoridis. Hepatocellular carcinoma: The virus or the liver?Liver International 2023; 43(S1): 22 doi: 10.1111/liv.15253
140
Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related CancersInternational Journal of Molecular Sciences 2022; 23(19): 11188 doi: 10.3390/ijms231911188
141
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updatesExploration of Targeted Anti-tumor Therapy 2024; 5(1): 120 doi: 10.37349/etat.2024.00209
142
Mirco Glitscher, Eberhard Hildt, Daniela Bender. Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und TumorentstehungBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2022; 65(2): 228 doi: 10.1007/s00103-021-03482-y
143
Luis E. Gomez-Quiroz, Sonia Roman. Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in MexicoAnnals of Hepatology 2022; 27: 100649 doi: 10.1016/j.aohep.2021.100649
144
Wei-Syun Hu, Cheng-Li Lin. Sodium-Glucose Cotransporter-2 Inhibitor versus Beta-Blocker Use for Hepatocellular Carcinoma Risk among People with Hepatitis B or C Virus Infection and Diabetes MellitusCancers 2023; 15(7): 2104 doi: 10.3390/cancers15072104
145
Chen Shen, Yi Cao, Guoqiang Qi, Jian Huang, Zhi-Ping Liu. Discovering pathway biomarkers of hepatocellular carcinoma occurrence and development by dynamic network entropy analysisGene 2023; 873: 147467 doi: 10.1016/j.gene.2023.147467
146
Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma. Applications of human organoids in the personalized treatment for digestive diseasesSignal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01194-6
147
Rui Qiang, Yanbo Li, Xincan Dai, Wenliang Lv. NLRP3 inflammasome in digestive diseases: From mechanism to therapyFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.978190
148
Yung-Fang Hsiao, Shao-Bin Cheng, Chia-Yu Lai, Hsiao-Tien Liu, Shih-Chien Huang, Yi-Chia Huang. The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular CarcinomaNutrients 2021; 13(11): 4071 doi: 10.3390/nu13114071
149
Yujian Liu, Jingrui Yang, Rui-Sheng Ke, Lupeng Wu, Zaifa Hong, Ping Guo, Liuxing Feng, Zhimin Li. LINC02875 Upregulation Contributed to Poor Prognosis for the Hepatocellular Carcinoma and Progression for the Cancerous CellsHormone and Metabolic Research 2022; 54(11): 760 doi: 10.1055/a-1913-8223
150
Pin Zhao, Samiullah Malik, Shaojun Xing. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.677926
151
Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil. Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic TechniquesCureus 2024;  doi: 10.7759/cureus.72239